• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近视矫正的五年随访:采用中央端口设计的后房型有晶状体眼人工晶状体

Five-Year Follow-up of Correction of Myopia: Posterior Chamber Phakic Intraocular Lens With a Central Port Design.

作者信息

Alfonso José F, Fernández-Vega-Cueto Luis, Alfonso-Bartolozzi Belén, Montés-Micó Robert, Fernández-Vega Luis

出版信息

J Refract Surg. 2019 Mar 1;35(3):169-176. doi: 10.3928/1081597X-20190118-01.

DOI:10.3928/1081597X-20190118-01
PMID:30855094
Abstract

PURPOSE

To assess the long-term correction of moderate to high myopia using a posterior chamber phakic intraocular lens with a central port design.

METHODS

Uncorrected (UDVA) and corrected (CDVA) distance visual acuities, refraction, intraocular pressure (IOP), endothelial cell density (ECD), vault, and adverse events over a 5-year period were evaluated retrospectively.

RESULTS

A total of 147 eyes (83 patients) were evaluated. Mean postoperative UDVA and CDVA were 0.05 ± 0.11 and 0.02 ± 0.08 logMAR at 1 year and 0.13 ± 0.18 and 0.02 ± 0.09 logMAR at 5 years, respectively. More than 95% of eyes achieved CDVA of 20/25 or better at both follow-up periods. CDVA was unchanged or improved from one to three or more lines in all eyes. Preoperatively, mean spherical equivalent (SE) was -9.20 ± 3.02 diopters (D). At 1 year, the mean SE was -0.17 ± 0.26 D, with 91.53% of eyes within ±0.50 D and 100% of eyes within ±1.00 D of the target. At 5 years, the mean SE was -0.44 ± 0.47 D, with 67.4% of eyes within ±0.50 D and 90.1% of eyes within ±1.00 D of the target. Mean IOP was 12.74 ± 1.65 and 13.0 ± 2.03 mm Hg, at 1 and 5 years, respectively. No significant rise in IOP (> 20 mm Hg) occurred during the follow-up period. Mean ECD was 2,696 ± 358 and 2,645 ± 359 cells/mm at 1 and 5 years, respectively, representing a non-significant loss of 0.43% from preoperative values (P = .304). Mean vault changed significantly from 398 ± 187 µm at 1 year to 340 ± 163 µm at 5 years (P < .001). No intraoperative or postoperative complications or adverse events occurred during the follow-up period.

CONCLUSIONS

The good long-term outcomes found in this study support the use of this lens with a central port design for the correction of moderate to high myopia. [J Refract Surg. 2019;35(3):169-176.].

摘要

目的

使用具有中央端口设计的后房型有晶状体眼人工晶状体评估中高度近视的长期矫正效果。

方法

回顾性评估5年期间的未矫正远视力(UDVA)、矫正远视力(CDVA)、屈光、眼压(IOP)、内皮细胞密度(ECD)、前房深度以及不良事件。

结果

共评估了147只眼(83例患者)。术后1年时平均UDVA和CDVA分别为0.05±0.11和0.02±0.08 logMAR,5年时分别为0.13±0.18和0.02±0.09 logMAR。在两个随访期内,超过95%的眼睛CDVA达到20/25或更好。所有眼睛的CDVA保持不变或提高了一行或多行。术前平均球镜等效度(SE)为-9.20±3.02屈光度(D)。1年时,平均SE为-0.17±0.26 D,91.53%的眼睛在目标值±0.50 D范围内,100% 的眼睛在目标值±1.00 D范围内。5年时,平均SE为-0.44±0.47 D,67.4%的眼睛在目标值±0.50 D范围内,90.1%的眼睛在目标值±1.00 D范围内。1年和5年时平均眼压分别为12.74±1.65和13.0±2.03 mmHg。随访期间未出现眼压显著升高(>20 mmHg)的情况。1年和5年时平均ECD分别为2,696±358和2,645±359个细胞/mm²,较术前值无显著下降,下降了0.43%(P = .304)。平均前房深度从1年时的398±187 µm显著变化为5年时的340±163 µm(P < .001)。随访期间未发生术中或术后并发症或不良事件。

结论

本研究中发现的良好长期结果支持使用这种具有中央端口设计的晶状体来矫正中高度近视。[《屈光手术杂志》。2019年;35(3):169 - 176。]

相似文献

1
Five-Year Follow-up of Correction of Myopia: Posterior Chamber Phakic Intraocular Lens With a Central Port Design.近视矫正的五年随访:采用中央端口设计的后房型有晶状体眼人工晶状体
J Refract Surg. 2019 Mar 1;35(3):169-176. doi: 10.3928/1081597X-20190118-01.
2
Posterior chamber phakic intraocular lens to correct myopia: long-term follow-up.后房型有晶状体眼人工晶状体矫正近视:长期随访。
J Cataract Refract Surg. 2013 Jul;39(7):1023-8. doi: 10.1016/j.jcrs.2013.01.041. Epub 2013 May 8.
3
Medium-term visual, refractive, and intraocular stability after implantation of a posterior chamber phakic intraocular lens to correct moderate to high myopia.后房型有晶状体眼人工晶状体植入矫正中高度近视的中期视力、屈光度和眼内稳定性。
J Cataract Refract Surg. 2011 Oct;37(10):1791-8. doi: 10.1016/j.jcrs.2011.04.034.
4
Safety and Efficacy of a New Phakic Posterior Chamber IOL for Correction of Myopia: 3 Years of Follow-up.新型有晶状体眼后房型人工晶状体矫正近视的安全性和有效性:3年随访
J Refract Surg. 2018 Dec 1;34(12):817-823. doi: 10.3928/1081597X-20181105-01.
5
Posterior chamber collagen copolymer phakic intraocular lens with a central hole to correct myopia: One-year follow-up.带中央孔的后房胶原共聚物有晶状体眼人工晶状体矫正近视:一年随访
J Cataract Refract Surg. 2015 Jun;41(6):1153-9. doi: 10.1016/j.jcrs.2014.10.030.
6
Correction of Moderate to High Myopia with a Foldable, Angle-Supported Phakic Intraocular Lens: Results from a 5-Year Open-Label Trial.折叠式有角巩膜支持的前房型人工晶状体矫正中高度近视:5 年开放标签试验结果。
Ophthalmology. 2016 May;123(5):1027-35. doi: 10.1016/j.ophtha.2015.12.028. Epub 2016 Feb 11.
7
Pilot study of a new posterior chamber phakic intraocular lens (epi.lens) for high myopia.高度近视新型后房有晶状体眼人工晶状体(epi.lens)的初步研究。
J Refract Surg. 2011 Dec;27(12):858-62. doi: 10.3928/1081597X-20111017-01. Epub 2011 Nov 10.
8
Five-year functional outcomes and vault of -20 diopter myopic phakic intraocular lens implantation.-20 屈光度近视有晶状体眼人工晶状体植入术的五年功能结局及眼杯情况
J Cataract Refract Surg. 2015 Dec;41(12):2724-30. doi: 10.1016/j.jcrs.2015.07.032.
9
Clinical outcomes after implantation of a posterior chamber collagen copolymer phakic intraocular lens with a central hole for myopic correction.中央孔型后房胶原共聚物有晶状体眼人工晶状体植入术后的临床疗效观察。
J Cataract Refract Surg. 2013 Jun;39(6):915-21. doi: 10.1016/j.jcrs.2013.01.036.
10
Three-year follow-up of posterior chamber toric phakic intraocular lens implantation for the correction of high myopic astigmatism in eyes with keratoconus.后房型有晶体眼散光人工晶状体植入矫正圆锥角膜眼高度近视散光的三年随访
Br J Ophthalmol. 2015 Feb;99(2):177-83. doi: 10.1136/bjophthalmol-2014-305612. Epub 2014 Aug 21.

引用本文的文献

1
Implantation of a posterior chamber phakic intraocular lens on Bruch's membrane opening-minimum rim width, retinal nerve fiber layer, and macular thickness.在布鲁赫膜开口处植入后房型有晶状体眼人工晶状体——最小边缘宽度、视网膜神经纤维层及黄斑厚度
Int J Ophthalmol. 2025 Sep 18;18(9):1658-1664. doi: 10.18240/ijo.2025.09.06. eCollection 2025.
2
Quantitative analysis of iris-ciliary angle area to optimize ICL selection: a retrospective study.虹膜睫状体角面积的定量分析以优化有晶体眼人工晶体(ICL)的选择:一项回顾性研究
BMC Ophthalmol. 2025 Aug 27;25(1):488. doi: 10.1186/s12886-025-04295-2.
3
Objective and subjective outcomes following implantable collamer lens (ICL) implantation for the correction of myopia.
植入式角膜接触镜(ICL)植入矫正近视后的客观和主观结果。
Oman J Ophthalmol. 2025 Jun 24;18(2):187-192. doi: 10.4103/ojo.ojo_171_24. eCollection 2025 May-Aug.
4
[Toric-ICL shows better predictability and efficacy than FS-LASIK for myopia correction in patients with moderate to high myopia and astigmatism].对于中高度近视合并散光患者,散光型有晶体眼人工晶体植入术(Toric-ICL)在近视矫正方面比飞秒激光制瓣准分子原位角膜磨镶术(FS-LASIK)显示出更好的可预测性和疗效。
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Jun 20;45(6):1113-1121. doi: 10.12122/j.issn.1673-4254.2025.06.01.
5
A pilot study of deep learning for automatic contouring of sulcus-to-sulcus diameter in ultrasound biomicroscopy.一项关于深度学习用于超声生物显微镜中沟到沟直径自动轮廓描绘的初步研究。
Graefes Arch Clin Exp Ophthalmol. 2025 Mar 22. doi: 10.1007/s00417-025-06764-2.
6
Long-term changes in classified higher-order aberrations after implanting an EVO intraocular collamer lens.植入EVO人工晶状体后分类高阶像差的长期变化。
BMC Ophthalmol. 2025 Mar 17;25(1):138. doi: 10.1186/s12886-025-03932-0.
7
Urrets-Zavalia syndrome and secondary acute-angle closure glaucoma induced by implantable collamer lens.乌雷茨-扎瓦利亚综合征及可植入式角膜胶原交联晶状体所致继发性急性闭角型青光眼
Proc (Bayl Univ Med Cent). 2024 Nov 8;38(2):191-194. doi: 10.1080/08998280.2024.2418729. eCollection 2025.
8
Evaluation of retinal and choroidal microvascular alteration after ICL V4c implantation based on OCTA.基于 OCTA 评价 ICL V4c 植入术后视网膜及脉络膜微血管改变。
BMC Ophthalmol. 2024 Nov 6;24(1):487. doi: 10.1186/s12886-024-03752-8.
9
Comprehensive assessment of corneal microstructural changes following V4c implantable collamer lens surgery using in vivo confocal microscopy.应用活体共聚焦显微镜评估 V4c 可折叠式人工晶状体植入术后角膜的微观结构变化。
BMC Ophthalmol. 2024 Sep 19;24(1):408. doi: 10.1186/s12886-024-03677-2.
10
Clinical observations of EVO-ICL implantation with single incision without viscoelastic agent.EVO-ICL 植入术中应用单切口且不使用黏弹剂的临床观察。
BMC Ophthalmol. 2024 Aug 14;24(1):344. doi: 10.1186/s12886-024-03587-3.